Sygnis Acquires C.B.S. Scientific with Heuking Kühn Lüer Wojtek
January, 2017 - Duesseldorf, Germany
A team of Heuking Kühn Lüer Wojtek led by partner Dr. Thorsten Kuthe advised Sygnis AG on the acquisition of C.B.S. Scientific Company Inc. in San Diego. Sygnis hopes to achieve sales synergies and a large potential for sales growth. It expects to realize cost savings by merging C.B.S. Scientific with the San Diego facilities of Expedeon.
C.B.S. Scientific Company Inc. is a provider of life science instruments. The company is headquartered in San Diego, USA. Estimated 2016 sales exceed $1.5 million.
Sygnis AG, based in Germany, specializes in the development and marketing of innovative products for the life science sector with special focus in the genetic and proteomic environments, DNA amplification and sequencing. The company is listed on the German Stock Exchange in the Prime Standard segment.
The team led by Dr. Thorsten Kuthe advises Sygnis on a regular basis, most recently on the acquisition of Expedeon.
Counsel to Sygnis AG
Heuking Kühn Lüer Wojtek:
Dr. Thorsten Kuthe (Lead),
Meike Dresler-Lenz, Christopher Görtz (all Corporate/M&A), Cologne
